The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Is Atripla a starter ART?
Sep 9, 2007

Hi Dr. Pierone

I am 41 years old and have recently stared on Atripla. I also have been taking Lexapro for about 24 months as well. My viral load in July '07 was 58k and my CD4 count was 227. I have never taken HIV meds before and have tested negative to any HIV drug resistance. Is Atripla the best med to start ART on and what long term affects will this drug have on my kidneys and liver?

Response from Dr. Pierone

Hello, and thanks for posting.

Based on the currently available data, a strong argument can be made that Atripla is the best starting regimen for HIV infection at this time. This medication is not for everyone of course and there will be individuals who will do better with an alternative cocktail. The long-term effects on the liver and kidneys beyond 5 years are not known since this combination product contains newer medications. However, the side effect profile is better than the previous cocktails, so this suggests that there will be less long-term toxicity as well.

my mouth is burning , i need help?
HIV treatment not available in Africa, how long until I die?

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint